The Effects of Varenicline on Alcohol Seeking and Self-Administration in Baboons

Alcoholism: Clinical and Experimental Research

Volumn 38, Issue 2, 2014, Pages 376-383

  Kaminski, Barbara J ^a   Weerts, Elise M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Craving; Cues; Drinking; Ethanol; Self Administration

Indexed keywords

ALCOHOL; VARENICLINE;

ALCOHOL SEEKING BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BEVERAGE; CONTROLLED STUDY; DRINKING; DRINKING BEHAVIOR; DRUG EFFECT; DRUG SELF ADMINISTRATION; MALE; NONHUMAN; PAPIO ANUBIS; PRIORITY JOURNAL;

CRAVING; CUES; DRINKING; ETHANOL; SELF-ADMINISTRATION;

ALCOHOL DRINKING; ANIMALS; BENZAZEPINES; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-SEEKING BEHAVIOR; ETHANOL; MALE; PAPIO; QUINOXALINES; SELF ADMINISTRATION;

EID: 84893118636     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.12233     Document Type: Article

References (37)

1. Anton R, O'Malley S, Ciraulo D, Cisler R, Couper D, Donovan D (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295:2003-2017.
2. Ator NA, Griffiths RR (1992) Oral self-administration of triazolam, diazepam, and ethanol in the baboon: drug reinforcement and benzodiazepine physical dependence. Psychopharmacology 108:301-312.
3. Belknap J, Crabbe J, Young E (1993) Voluntary consumption of ethanol in 15 inbred mouse strains. Psychopharmacology 112:503-510.
4. Bito-Onon J, Simms J, Chatterjee S, Holgate J, Bartlett S (2011) Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats. Addict Biol 16:440-449.
5. Cahill K, Stead L, Lancaster T (2012) Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 4:CD006103.
6. Chatterjee S, Bartlett S (2010) Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders. CNS Neurol Disord Drug Targets 9:60-76.
7. Childress A, Ehrman R, Rohsenow D, Robbins S, O'Brien C (1992) Classically conditioned factors in drug dependence, in Substance Abuse: A Comprehensive Textbook (Lowinson P, Luiz P, Millman RB, Langard G eds), pp 56-69. Williams and Wilkins, Baltimore.
8. Childs E, Roche D, King A, de Wit H (2012) Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements. Alcohol Clin Exp Res 36:906-914.
9. Coe J, Brooks P, Vetelino M, Wirtz M, Arnold E, Huang J, Sands S, Davis T, Lebel L, Fox C, Shrikhande A, Heym J, Schaeffer E, Rollema H, Lu Y, Mansbach R, Chambers L, Rovetti C, Schulz D, Tingley FD, O'Neill B (2005) Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem 48:3474-3477.
10. Collins B, Brandon T (2002) Effects of extinction context and retrieval cues on alcohol cue reactivity among nonalcoholic drinkers. J Consult Clin Psychol 70:390-397.
11. Crombag H, Shaham Y (2002) Renewal of drug seeking by contextual cues after prolonged extinction in rats. Behav Neurosci 116:169-173.
12. Duke AN, Kaminski BJ, Weerts E (in press) Baclofen effects on alcohol seeking, self-administration and extinction of seeking responses in a within-session design in baboons. Addict Biol doi: 10.1111/j.1369-1600.2012.00448.x [Epub ahead of print].
13. Egli M (2005) Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism? Addict Biol 10:309-319.
14. Ericson M, Lof E, Stomberg R, Soderpalm B (2009) The smoking cessation medication varenicline attenuates alcohol and nicotine interactions in the rat mesolimbic dopamine system. J Pharmacol Exp Ther 329:225-230.
15. Fucito L, Toll B, Wu R, Romano D, Tek E, O'Malley S (2011) A preliminary investigation of varenicline for heavy drinking smokers. Psychopharmacology 215:655-663.
16. Ginsburg BC, Lamb RJ (2013) Effects of varenicline on ethanol- and food-maintained responding in a concurrent access procedure. Alcohol Clin Exp Res 37:1228-1233.
17. Grant KA, Bennett AJ (2003) Advances in nonhuman primate alcohol abuse and alcoholism research. Pharmacol Ther 100:235-255.
18. Grant KA, Leng X, Green HL, Szeliga KT, Rogers LS, Gonzales SW (2008) Drinking typography established by scheduled induction predicts chronic heavy drinking in a monkey model of ethanol self-administration. Alcohol Clin Exp Res 32:1824-1838.
19. Gulliver SB, Rohsenow DJ, Colby SM, Dey AN, Abrams DB, Niaura RS, Monti PM (1995) Interrelationship of smoking and alcohol dependence, use and urges to use. J Stud Alcohol 56:202-206.
20. Hendrickson L, Zhao-Shea R, Pang X, Gardner P, Tapper A (2010) Activation of alpha4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption. J Neurosci 30:10169-10176.
21. Henningfield JE, Ator NA, Griffiths RR (1981) Establishment and maintenance of oral ethanol self-administration in the baboon. Drug Alcohol Depend 7:113-124.
22. Kamens H, Andersen J, Picciotto M (2010) The nicotinic acetylcholine receptor partial agonist varenicline increases the ataxic and sedative-hypnotic effects of acute ethanol administration in C57BL/6J mice. Alcohol Clin Exp Res 34:2053-2060.
23. Kaminski BJ, Duke AN, Weerts EM (2012) Effects of naltrexone on alcohol drinking patterns and extinction of alcohol seeking in baboons. Psychopharmacology 223:55-66.
24. Kaminski BJ, Goodwin AK, Wand G, Weerts EM (2008) Dissociation of alcohol-seeking and consumption under a chained schedule of oral alcohol reinforcement. Alcohol Clin Exp Res 32:1014-1022.
25. Litten R, Egli M, Heilig M, Cui C, Fertig J, Ryan M, Falk D, Moss H, Huebner R, Noronha A (2012) Medications development to treat alcohol dependence: a vision for the next decade. Addict Biol 17:513-527.
26. McKee S, Harrison E, O'Malley S, Krishnan-Sarin S, Shi J, Tetrault J, Picciotto M, Petrakis I, Estevez N, Balchunas E (2009) Varenicline reduces alcohol self-administration in heavy-drinking smokers. Biol Psychiatry 66:185-190.
27. Mitchell J, Teague C, Kayser A, Bartlett S, Fields H (2012) Varenicline decreases alcohol consumption in heavy-drinking smokers. Psychopharmacology 223:299-306.
28. NIAAA (2007) Helping Patients Who Drink Too Much, A Clinician's Guide, updated Edition 2005, NIH Publication No. 07-3769, reprinted May 2007.
29. O'Malley S, Froehlich J (2003) Advances in the use of naltrexone: an integration of preclinical and clinical findings. Recent Dev Alcohol 16:217-245.
30. Pettinati H, O'Brien C, Rabinowitz A, Wortman S, Oslin D, Kampman K, Dackis C (2006) The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. J Clin Psychopharmacol 26:610-625.
31. Rollema H, Hajos M, Seymour PA, Kozak R, Majchrzak MJ, Guanowsky V, Horner WE, Chapin DS, Hoffmann WE, Johnson DE, McLean S, Freeman J, Williams KE (2009) Preclinical pharmacology of the a4b2 nAChR partial agonist varenicline related to effects on reward, mood and cognition. Biochem Pharmacol 78:813-824.
32. Samson HH, Fromme K (1984) Social drinking in a simulated tavern: an experimental analysis. Drug Alcohol Depend 14:141-163.
33. Söderpalm B, Ericson M, Olausson P, Blomqvist O, Engel J (2000) Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. Behav Brain Res 113:85-96.
34. Spiga R, Macenski MJ, Meisch RA, Roache JD (1997) Human ethanol self-administration. I: Interaction between response requirement and ethanol dose. Behav Pharmacol 8:91-100.
35. Steensland P, Simms J, Holgate J, Richards J, Bartlett S (2007) Varenicline, an 42 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. PNAS 104:12518-12523.
36. Weerts EM, Goodwin AK, Kaminski BJ, Hienz RD (2006) Environmental cues, alcohol seeking, and consumption in baboons: effects of response requirement and duration of alcohol abstinence. Alcohol Clin Exp Res 30:2026-2036.
37. Wouda J, Riga D, De Vries W, Stegeman M, van Mourik Y, Schetters D, Schoffelmeer A, Pattij T, De Vries T (2011) Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control. Psychopharmacology 216:267-277.